Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
11/2012
11/07/2012CN102764311A Xiao Jin dispensible tablet and preparation method thereof
11/07/2012CN102764309A Medicament for treating bone fractures
11/07/2012CN102764264A Celecoxib solid composition with high dissolution, preparation method and application
11/07/2012CN102764235A Strontium ranelate dry suspension and preparation method thereof
11/07/2012CN102764173A Vertebra pad for treating vertebra pathology, and preparation method thereof
11/07/2012CN102362995B Chinese medicinal preparation for treating acute gouty arthritis, and preparation method thereof
11/07/2012CN102327279B Triptolide and lonicerin compatible medicine composition, preparation and application thereof
11/07/2012CN102258602B Chinese medicinal composition for treating rheumatism and rheumatoid and preparation method thereof
11/07/2012CN102247486B Bone health care marrow filling capsule
11/07/2012CN102247458B Capsule for warming collaterals and relaxing tendons
11/07/2012CN102198172B Externally-applied powder for treating rheumatic arthralgia and preparation method thereof
11/07/2012CN102188661B Traditional Chinese medicine for removing arthralgia and preparation method thereof
11/07/2012CN102188553B Medicinal wine for oral and external administration and manufacturing method thereof
11/07/2012CN102114245B Special solvent for daidzein pre-emulsified injection and preparation method and purpose thereof
11/07/2012CN101991710B Medical vertebral rehabilitation powder for treating prolapsed intervertebral disease
11/07/2012CN101991633B Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof
11/07/2012CN101980705B Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
11/07/2012CN101891817B Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof
11/07/2012CN101652355B N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
11/07/2012CN101648000B Application of cobrotoxin in preparing medicine for treating arthritis
11/07/2012CN101518521B New medical application of cedrol
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012CA2493083C Composition for cytocompatible, injectable, self-gelling chitosan solutions for encapsulating and delivering live cells or biologically active factors
11/06/2012CA2393467C Chordin-like molecules and uses thereof
11/01/2012WO2012147916A1 Amide compound and pharmaceutical application therefor
11/01/2012WO2012147470A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012WO2012147102A1 Bioactive fractions and compounds from dalbergia sissoo for the prevention or treatment of osteo-health related disorders
11/01/2012WO2012146936A1 Pyrrolnitrin derivatives
11/01/2012WO2012146773A1 Composition for prevention and treatment of rheumatoid arthritis
11/01/2012WO2012146659A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012WO2012146657A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012WO2012146194A1 Extracts of cynanchum sp. and active ingredients contained therein in use of arthritis treatment
11/01/2012WO2012095743A3 Adipose -derived mesenchymal stem cells for intralymphatic administration in autoimmune and inflammatory diseases
11/01/2012US20120277307 Method for Treating Osteoarthritis
11/01/2012US20120277303 Equol-containing fermentation product of soybean embryonic axis, and method for production thereof
11/01/2012US20120277300 Compositions and methods for inducing bone growth and inhibiting bone loss
11/01/2012US20120277298 Flavanones-containing food compositions
11/01/2012US20120277289 Activity generating delivery molecules
11/01/2012US20120277279 Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune Conditions
11/01/2012US20120277277 Methods of Treating a Hyperproliferative Disorder or Inhibiting Cell Growth in a Mammal
11/01/2012US20120277259 Substituted benzofused derivatives and their use as vanilloid receptor ligands
11/01/2012US20120277255 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277248 Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
11/01/2012US20120277247 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012US20120277240 Substituted aminotetrahydrothiopyrans and derivatives thereof as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
11/01/2012US20120277225 Inhibitors of bruton's tyrosine kinase
11/01/2012US20120277219 Novel pyridopyrazine derivatives, process of manufacturing and uses thereof
11/01/2012US20120277215 Organic Compounds
11/01/2012US20120277192 Aminopyrimidines as syk inhibitors
11/01/2012US20120277182 Anoectochilus spp. polysaccharide extracts for stimulating growth of advantageous bacteria, stimulating release of granulocyte colony-stimulating factor, modulating t helper cell type i, and/or modulating t helper cell type ii and uses of the same
11/01/2012US20120277174 New macrolides and their use
11/01/2012US20120277169 Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
11/01/2012US20120277157 Disease treatment via antimicrobial peptides or their inhibitors
11/01/2012US20120277156 Inhibition of pathological bone formation
11/01/2012US20120277152 Compressed high density fibrous polymers suitable for implant
11/01/2012US20120277142 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same
11/01/2012US20120276225 Phytoestrogenic nutraceutical composition from palm leaf extract
11/01/2012US20120276215 Therapeutic Conditioned Media
11/01/2012US20120276214 Infant nutrition with protease inhibitor
11/01/2012US20120276204 Bone Growth Compositions and Methods
11/01/2012US20120276203 Collagen matrix for cell therapy
11/01/2012US20120276202 Collagen matrix for tissue engineering
11/01/2012US20120276192 Compositions and methods for sirna inhibition of icam-1
11/01/2012US20120276191 Treatment and Diagnosis of Macrophage Mediated Disease
11/01/2012US20120276173 Glycosaminoglycan Compositions in Combination with Stem Cells
11/01/2012US20120276164 Implantable paste and its use
11/01/2012US20120276150 Soft tissue wrap
11/01/2012US20120276143 Probiotic bifidobacterium strain
11/01/2012US20120276126 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
11/01/2012US20120276111 Methods and compositions for treating conditions associated with angiogenesis using a vascular adhesion protein-1 (vap-1) inhibitor
11/01/2012US20120276102 Methods of treatment utiliziing binding proteins of the interleukin-21 receptor
11/01/2012US20120276087 Methods and compositions using pde4 inhibitors for the treatment and management of autoimmune and inflammatory diseases
11/01/2012US20120276070 Induced Pluripotent Stem Cells and Related Methods
11/01/2012US20120276069 Hydrogels based on polymers of dextran tyramine and tyramine conjugates of natural polymers
11/01/2012US20120276066 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
11/01/2012US20120276052 Transgene delivering retrovirus targeting collagen exposed at site of tissue injury
11/01/2012US20120276049 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences
11/01/2012US20120275996 IL-1 Binding Proteins
11/01/2012CA2834255A1 Peptide for inducing regeneration of tissue and use thereof
11/01/2012CA2833963A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012CA2833942A1 Novel compound useful for the treatment of degenerative and inflammatory diseases
11/01/2012CA2833493A1 Amide compound and pharmaceutical application therefor
10/2012
10/31/2012EP2518496A2 BMP-1 procollagen C-proteinase for diagnosis and treatment of bone and soft tissue defects and disorders
10/31/2012EP2518056A1 Seven-membered ring compound and pharmaceutical use therefor
10/31/2012EP2517718A2 Treatment of T-cell mediated diseases
10/31/2012EP2517699A1 Composition for prevention and treatment of arthritis
10/31/2012EP2516628A1 Treatment of bone fracture
10/31/2012EP2516467A2 Compositions comprising tnf-alpha and il-6 antagonists and methods of use thereof
10/31/2012EP2516434A1 Fused heteroaromatic pyrrolidinones as syk inhibitors
10/31/2012EP2516433A1 Substituted n-(1h-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cfms inhibitors
10/31/2012EP2515929A1 Methods and use related to humanin and humanin-like peptides
10/31/2012EP2515897A1 A combination for the treatment of osteoarthritis
10/31/2012EP2515655A1 1h-pyrazolo[3,4-beta]pyridines and therapeutic uses thereof
10/31/2012CN102762559A Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators
10/31/2012CN102762228A Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
10/31/2012CN102757945A Human urate oxidase protein and preparation method and polyethylene glycol composite thereof
10/31/2012CN102757515A Method for extracting high-purity flavonoid and pectin from citrus peel
10/31/2012CN102757499A Antibody for resisting osteopontin chimerism, preparation method and application thereof in preparation of drugs for treating osteoporosis
10/31/2012CN102757448A Macrocyclic kinase inhibitor compound, preparation method and application thereof as drug
10/31/2012CN102757441A Furano[3,2-g]chromene compounds and applications thereof
1 ... 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 ... 820